Report from Vox Sanguinis
Chairperson and committee
There have been no changes in the Editorial Board during the last year. The sections and the Section Editors are:
Blood Component Collection and Production: Denese Marks (Australia)
Cellular Therapies: Ziggy M. Szczepiorkowski (USA)
Donors and Donations: Katja van den Hurk (the Netherlands)
Haemovigilance: Claudia S. Cohn (USA)
Immunohaematology and Immunogenetics: Jill R. Storry (Sweden)
Patient Blood Management: Nelson H. Tsuno (Japan)
Reviews: Leo van de Watering (the Netherlands) and Ziggy M Szczepiorkowski
Transfusion Medicine and New Therapies: Pierre Tiberghien
Transfusion-transmitted Disease and its Prevention: Sheila O’Brien (Canada)
International Forum: Nancy M. Dunbar.
Miquel Lozano holds the position of Editor‐in‐Chief (EiC).
Nancy M. Dunbar has expressed to me in February, her wish to step down as editor of the International Forum section at the end of 2025. We will start looking for her replacement with enough time to ensure a smooth transition between Nancy and the new Editor. I informed the Vox Sanguinis Standing Committee in the meeting of March 19th that we could invite Arwa Z. Al Riyami from Oman to occupy the position. The suggestion was approved.
Maria Davie continues as technical editor, to the full satisfaction of the EiC, the Editorial Board and the authors. Claire Dowbekin has continued as Journal Publishing Manager at Wiley and Thomas Sinden has joined her as Wiley representative of the economic aspects of the relationship between Wiley and ISBT.
Meetings and Teleconferences
We hold a face-to-face Editorial Board meeting on 28th June 2024, immediately after the ISBT International meeting in Barcelona, at the facility of the Blood and Tissue Bank of Catalonia, kindly provided by her Director, Dr. Anna Millán.
Activities during the period
Vox Sanguinis metrics refer to the volume of a given year. In 2024, volume number 119, Vox Sanguinis published 12 issues with a total of approximately 1,250 pages, featuring 179 articles (an increase of 17.76% over 2023). What is interesting is that in 2023 we published 152 articles, 30.9% being hybrid open access; in 2024, 41.3% were hybrid open access, an increase of the 33.6%. Since April 2024, the issues are on-line only.
In 2024, we received 394 submissions, an increase of 14,87% compared with 2023, resulting in an acceptance rate of 45.6 % (3.4% increase over 2023).
In 2024 the time between submission and online publication increased a 16.82% to 125 days, probably due to some papers that has taken longer than usual to get acceptance.
In 2024, 406,050 articles were downloaded from the Vox Sanguinis website, representing an increase of 5.3% over 2024.
Despite the increase in the number of manuscripts submitted, published and downloaded, the 2-year citation trend decreased by 3.1% to 310.
We are currently preparing three themed issues for 2025, one regarding Blood Component Preparation led by Denese Marks, another one about Artificial Intelligence in Transfusion Medicine, led by Pierre Tiberghien and Arwa Z. Al Riyami and a third one about Disasters Preparedness and Blood Supply co-edited by Nelson Tsuno, Claudia Cohn and Agneta Wikman.
